Amid Zolgensma crisis, Novartis gets a gene therapy boost as NICE embraces Luxturna

Amid Zolgensma crisis, Novartis gets a gene therapy boost as NICE embraces Luxturna

Can Gene Therapy Become The Cure For Blindness?

  Κάντε like στη σελίδα μας στο facebook για να μαθαίνετε πρώτοι όλα τα νέα!!    With the first gene therapy for blindness in the market, the door has been opened for a new wave of gene therapy treatments with the potential to cure genetic blindness.  In December 2017, the FDA approved Luxturna, the first … Συνεχίστε να διαβάζετε Can Gene Therapy Become The Cure For Blindness?.

Novo Nordisk nabs FDA nod for hemophilia A drug Esperoct but can’t launch until 2020

Novo Nordisk nabs FDA nod for hemophilia A drug Esperoct but can’t launch until 2020